TriSalus CMO receives new RSU and option grants
TriSalus Life Sciences, Inc. Chief Medical Officer Richard Henry received new equity compensation in the form of restricted stock units and stock options.
Rhea-AI Filing Summary
TriSalus Life Sciences, Inc. Chief Medical Officer Richard Henry received new equity compensation in the form of restricted stock units and stock options. He was granted 60,000 shares of common stock as restricted stock units, which will vest in four equal annual installments starting on June 29, 2027, assuming continued service. He also received an employee stock option for 120,000 shares of common stock at an exercise price of $4.74 per share, vesting over four years with one-fourth vesting on June 29, 2027 and the remainder monthly thereafter. Following these grants, he directly holds 90,000 shares of common stock and 253,000 stock options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 180,000 shares
Grant/Award
2 txns
Insider
Marshall Richard Henry
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 120,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 60,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 253,000 contracts (Direct);
Common Stock — 90,000 shares (Direct)
Footnotes (2)
- F1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award shall vest in four equal annual installments commencing on the one-year anniversary of the grant date of June 29, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
- F2. One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.
Key Figures
RSU grant size: 60,000 shares
Option grant size: 120,000 shares
Option exercise price: $4.74 per share
+5 more
8 metrics
RSU grant size
60,000 shares
Restricted stock units granted June 29, 2026
Option grant size
120,000 shares
Employee stock option granted June 29, 2026
Option exercise price
$4.74 per share
Exercise price for 120,000-share option
Option expiration
June 29, 2036
Expiration date of employee stock option
Common shares after grant
90,000 shares
Total common stock held directly after RSU grant
Options after grant
253,000 options
Total options held directly after new option award
RSU vesting schedule
4 annual installments
RSUs vest annually starting June 29, 2027
Option vesting pattern
1/4 at 1 year, then monthly
Option vests over four years from June 29, 2026
Key Terms
restricted stock units, RSU Award, vesting commencement date, Employee Stock Option, +1 more
5 terms
restricted stock units financial
"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSU Award financial
"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"
vesting commencement date financial
"One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of June 29, 2026"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Employee Stock Option financial
"Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
continuous service financial
"subject to the Reporting Person's continuous service with the Issuer on each respective vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did TriSalus Life Sciences (TLSI) grant to its CMO?
TriSalus granted Chief Medical Officer Richard Henry 60,000 restricted stock units and an option for 120,000 shares. These awards provide long-term equity incentives tied to company performance and continued employment over several years.
How do the new restricted stock units for TLSI’s CMO vest?
The 60,000 restricted stock units vest in four equal annual installments starting June 29, 2027. Each yearly tranche requires Richard Henry to remain in service with TriSalus Life Sciences through the applicable vesting date to receive the underlying shares.
What are the key terms of the new stock option granted by TLSI?
The employee stock option covers 120,000 shares of TriSalus common stock with a $4.74 exercise price. One-fourth vests on June 29, 2027, and the remaining shares vest monthly over 36 months, subject to continuous service, with expiration on June 29, 2036.
Are the recent TLSI insider transactions open-market buys or compensation grants?
The recent insider transactions are compensation-related grants, not open-market purchases or sales. Both the 60,000 restricted stock units and 120,000-share stock option were awarded to the Chief Medical Officer as part of his equity compensation package.
AI-generated analysis. How Rhea-AI works. Not financial advice.
